Early research and patient feedback demonstrate weight reduction and decreased inflammation with GLP-1 treatments for certain individuals
This has significant implications for the cost, risk exposure, and long-term feasibility of the treatment
Read article AJMC FDA approves oral semaglutide first GLP-1 pill for weight loss in adults Read article BUSINESS TODAY India's weight loss drug moment what happens when semaglutide goes generic Read article The Evidence India & Global 15.3% Average weight loss STEP 1 Trial 68 weeks 20% Reduction in heart attacks & strokes SELECT Trial NEJM 2023 71% Prediabetics restored to normal glucose OASIS 4 Trial 101M Indians living with diabetes ICMR-INDIAB 2023 254M Indians with generalised obesity ICMR-INDIAB National Study 2023 43.3% Indians metabolically obese at normal BMI ICMR-INDIAB-23, Indian Journal of Medical Research THE SCIENCE GLP-1 is a hormone naturally released by your gut after eating
Metabolic Research2026-07-22 Peptides Studied for Injury Recovery: BPC-157, TB-500, & Evidence This article explores the research into peptides like BPC-157 and TB-500 concerning their roles in tissue repair and regeneration
However, four fusions with a single point mutation (G2V, E15A, V19A and L26I) had potency at human GLP-1R similar to the target value and were investigated further for in vivo peptide stability and manufacturability
Managing Common Issues Mild reactions : If you notice redness, itching, or slight swelling, use a cool compress to soothe the area
)
